Barclays Maintains Equal-Weight on PTC Therapeutics, Raises Price Target to $31
Barclays Maintains Equal-Weight on PTC Therapeutics, Raises Price Target to $31
巴克萊銀行維持對Ptc Therapeutics的中性，將價格目標上調至31美元。
Barclays analyst Gena Wang maintains PTC Therapeutics (NASDAQ:PTCT) with a Equal-Weight and raises the price target from $25 to $31.
巴克萊銀行分析師Gena Wang認爲PTC Therapeutics (納斯達克: ptc therapeutics)應保持中性並將目標價格從$25上調至$31。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。